MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation by Ortega, Francisco J. et al.
MiRNA Expression Profile of Human Subcutaneous
Adipose and during Adipocyte Differentiation
Francisco J. Ortega1, Jose´ M. Moreno-Navarrete1, Gerard Pardo1, Monica Sabater1, Manuela Hummel2,
Anna Ferrer2, Jose I. Rodriguez-Hermosa4, Bartomeu Ruiz4, Wifredo Ricart1, Belen Peral3, Jose´ M.
Ferna´ndez-Real1*
1 Service of Diabetes, Endocrinology and Nutrition, Institut d’Investigacio´ Biome´dica de Girona (IdIBGi), CIBEROBN (CB06/03/0010) and Instituto de Salud Carlos III (ISCIII),
Girona, Spain, 2Microarray Unit, Center for Genomic Regulation (CRG), Universitat Pompeu Fabra (UPF), Barcelona, Spain, 3 Instituto de Investigaciones Biome´dicas
‘Alberto Sols’ (IIB), Consejo Superior de Investigaciones Cientı´ficas (CSIC) and Universidad Auto´noma de Madrid (UAM), Madrid, Spain, 4Department of Surgery, Institut
d’Investigacio´ Biome´dica de Girona (IdIBGi), Girona, Spain
Abstract
Background: Potential regulators of adipogenesis include microRNAs (miRNAs), small non-coding RNAs that have been
recently shown related to adiposity and differentially expressed in fat depots. However, to date no study is available, to our
knowledge, regarding miRNAs expression profile during human adipogenesis. Thereby, the aim of this study was to
investigate whether miRNA pattern in human fat cells and subcutaneous adipose tissue is associated to obesity and co-
morbidities and whether miRNA expression profile in adipocytes is linked to adipogenesis.
Methodology/Principal Findings: We performed a global miRNA expression microarray of 723 human and 76 viral mature
miRNAs in human adipocytes during differentiation and in subcutaneous fat samples from non-obese (n = 6) and obese with
(n = 9) and without (n = 13) Type-2 Diabetes Mellitus (DM-2) women. Changes in adipogenesis-related miRNAs were then
validated by RT-PCR. Fifty of 799 miRNAs (6.2%) significantly differed between fat cells from lean and obese subjects.
Seventy miRNAs (8.8%) were highly and significantly up or down-regulated in mature adipocytes as compared to pre-
adipocytes. Otherwise, 17 of these 799 miRNAs (2.1%) were correlated with anthropometrical (BMI) and/or metabolic
(fasting glucose and/or triglycerides) parameters. We identified 11 miRNAs (1.4%) significantly deregulated in subcutaneous
fat from obese subjects with and without DM-2. Interestingly, most of these changes were associated with miRNAs also
significantly deregulated during adipocyte differentiation.
Conclusions/Significance: The remarkable inverse miRNA profile revealed for human pre-adipocytes and mature adipocytes
hints at a closely crosstalk between miRNAs and adipogenesis. Such candidates may represent biomarkers and therapeutic
targets for obesity and obesity-related complications.
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Introduction
The development of adiposity involves extensive adipose tissue
remodeling at the cellular level and is dependent on the
coordinated interplay between adipocyte hypertrophy (increase
in cell size) and adipocyte hyperplasia (increase in cell number)
[1–4]. Hyperplasic component of adipose tissue is currently well
recognized [5–8] and refers both the recruitment and proliferation
of adipocyte precursor cells (also named pre-adipocytes) followed
by the complex process by which new fat cells are developed from
pre-adipocytes [1,2,9]. Looking for an in-depth understanding of
these processes, much attention has been given to the regulators
that modulate pre-adipocytes proliferation and differentiation
(also named adipogenesis). Both processes are tightly controlled,
in negative or positive ways, by a combination of multiple
transcription factors [10]. Potential regulators of adipogenesis
include microRNAs (miRNAs), small non-coding RNAs which
represents an abundant class of ,22-nucleotide length RNAs
evolutionarily highly conserved. MiRNAs expression levels have
been recently shown as differentially regulated in mice during in
vitro as well as in vivo adipogenesis [11].
Since its early discovery in 1993, miRNA expression profiles
and functions have been extensively studied. It is believed that
miRNAs control the post-transcriptional regulation of ,30% of
mammalian genes [12], either via degradation of target mRNAs
or by translational repression [13–15]. Through modifying
mRNAs availability and protein synthesis, miRNAs control many
cellular processes such as cell differentiation [16–18], growth,
proliferation and apoptosis [19–21]. Indeed, since miRNAs
expression is deeply related to cellular behavior and, eventually,
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9022
the correct development and function of body tissues, changes in
miRNAs expression profiles are being extensively studied in
human diseases such as cancer, osteoporosis, cardiac illness and
heart failure [22–25]. Moreover, miRNAs are attractive candi-
dates for regulating cell fate decisions and complex diseases since
the simultaneous coordination of a large number of target genes,
potentially accomplished by a single miRNA, may be a key-factor
to defining specific differentiated or pathogenic cell states.
Unlike cancer, few studies have aimed to define a miRNA
expression profile for adipose tissue and fat cells [11,26–28]. Xie
et al. [11] investigated the regulation and involvement of 373
miRNAs in fat cell development, enlarged fat depots and obesity
working with fat samples from mice and in vitro cultured 3T3-L1
cells. Otherwise, Klo¨ting et al. [26] performed a global miRNA
expression study of 155 miRNAs in both subcutaneous and
omental human fat depots of overweight and obese individuals.
Previously, Kajimoto et al. [28] (102 miRNAs) and Esau et al.
[27] (254 miRNAs) tried to identify by anti-sense inhibition of
miRNAs significantly deregulated in fully differentiated adipo-
cytes, key-miRNAs for adipocyte differentiation, working with
3T3-L1 and human fat cells, respectively.
In this study, we have profiled the expression of 799 mature
miRNAs (723 human and 76 viral) during adipogenesis of human
adipocytes and in subcutaneous adipose tissue samples from lean
and obese with and without Type-2 Diabetes Mellitus subjects. We
aimed to investigate whether miRNA expression profile in human
adipocytes changes during adipogenesis and whether this pattern
significantly differs between cells from obese or lean subjects, as
well as in subcutaneous fat depots. We found that the expression of
70 miRNAs was modulated in fully differentiated human
adipocytes. Fifty miRNAs significantly differed between either
pre- or mature adipocytes from lean and obese individuals. We
then examined whether modulation of the expression of these
miRNAs is also detected in subcutaneous fat depots.
Methods
Cell Culture
Cryopreserved human subcutaneous pre-adipocytes (Zen-BioH,
Inc.) from both lean (BMI,25.0 Kg/m2) and obese
(BMI.30.0 Kg/m2) subjects were plated, cultured and differen-
tiated according to manufacturers’ guidelines as described as
Supplemental Information (SI) in Materials and Methods S1. Three
biological replicates (n = 3 replicates/cell/day) were performed
during differentiation (days 0, 7 and 14 after starting differenti-
ation protocol) for each cell line.
Subjects and Samples
Twenty-eight adipose tissue biopsies were obtained from
subcutaneous fat depots of a group of women (n= 28) with Body
Mass Indexes (BMI) between 20 and 55 Kg/m2. They were
invited to participate at the Endocrinology Service of the Hospital
Universitari Dr. Josep Trueta de Girona (Girona, Spain). Informed
written consent was obtained after the purpose, nature, and
potential risks of the study were explained to all of them. The
experimental protocol was approved by the Ethics Committee of
the Hospital Dr. Josep Trueta of Girona. Human patient character-
ization as well as sample preparation is described in Table S1 and
Materials and Methods S1 files, respectively.
Microarray and Data Analysis
The analysis of 723 human and 76 viral mature miRNAs (799
miRNAs) was carried out for both in vitro and in vivo samples. Total
RNA, including mRNAs, small RNAs and microRNAs, was
extracted, purified and prepared from adipose tissue fragments
and cell debris using miRNeasyH Mini Kit (QIAgen). The integrity
of each RNA sample was checked with an Agilent BioanalyzerH
(Agilent Technologies). Human miRNA microarrays (Agilent Technol-
ogies), containing 13,737 probes corresponding to 799 miRNAs,
and 22 control probes, were then hybridized following manufac-
tures’ protocol. Microarray preparation, as well as statistical
analysis, is described in detail in Materials and Methods S1. Within
the miRNAs with significant test results we report only those which
have normalized (non-logged) signal intensities above 150 in at
least half of the samples involved in the respective comparison, and
which hence can be trusted not to represent ‘‘noise’’. Complete
miRNA microarray data from cells and human fat depots are
deposited into Gene Expression Omnibus (GEO) following
MIAME compliant guidelines (Accession numbers: GSE18469
and GSE18470, respectively; NCBI tracking system #15713167).
Gene Expression Analyses
Three mg of total RNA were reverse transcribed to cDNA using
High Capacity cDNAH Archive Kit (Applied Biosystems) according
to the manufacturers’ guidelines. MiRNAs were reverse tran-
scribed by TaqManH MicroRNA Reverse Transcription Kit
(Applied Biosystems). Gene expression was assessed by Real Time-
PCR using an ABI PrismH 7000 Sequence Detection System and
TaqManH technology suitable for relative gene expression
quantification as described in Materials and Methods S1.
Cyclophilin A (PPIA) and RNU48 were used such as
endogenous controls in each reaction for mRNA target genes
and target miRNAs, respectively. Fatty Acid Synthase (FAS),
Acetyl-Coenzyme A Carboxylase alpha (ACACA), Fatty Acid
Binding Protein 4 (FABP4), Peroxisome Proliferator-activated
Receptor Gamma (PPARg), Adiponectin (ADIPOQ), and Retinol
Binding Protein 4 (RBP4) were the target mRNAs. The miRNA
expression levels were assessed by RT-PCR for miR-210 (MIMAT
0000267), miR-221 (MIMAT 0000278), miR-503 (MIMAT
0002874), miR-424 (MIMA 0001341), miR-378 (MIMAT
0000732), and miR-30c (MIMAT 0000244). Gene expression
results are expressed, for miRNAs as well as for mRNAs, as
expression ratio relative to their respective endogenous control, as
described in Materials and Methods S1.
Statistical Analyses
Descriptive results of continuous variables are expressed as
mean6SEM unless otherwise indicated. Before statistical analysis,
normal distribution and homogeneity of the variances were
evaluated using Levene’s test. One-way ANOVA, for multiple
comparisons, using post-hoc by Bonferroni’s test when equal
variances could be assumed, was used to compare groups with
respect to continuous variables. Relation between quantitative
variables was tested using Pearson’s t-test. p,0.05 was considered as
statistically significant. The statistical analyses and graphics were
performed using the program SPSS (Chicago, IL) version 13.0.
Microarray statistical analyses are described in detail in Materials
and Methods S1.
Results
Differential miRNA Expression between Lean and Obese
Cell Lines before and after In Vitro Differentiation
The expression of 723 human and 76 viral mature miRNAs was
assessed using miRNA microarrays (Sanger miRBase94, v10.1) in
three biological replicates of human subcutaneous fat cells (Zen-Bio,
Inc.) from both lean (BMI,25 Kg/m2) and obese (BMI.30
MiRNAs, Adipocytes & Fat Depots
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9022
Kg/m2) subjects during adipocyte differentiation (days 0, 7 and
14). Data from the replicates were very consistent.
The expression levels of 40 (5.0%) in pre-adipocytes and 31
miRNAs (3.9% of the 799 miRNAs) in mature adipocytes (14th
day) significantly differed between cells from lean and obese
subjects (Table 1). Twenty-one of these miRNAS were common
for both pre-adipocytes and adipocytes. Surprisingly, miR-923 and
miR-210 levels showed an opposite expression pattern between
cell lines, since both were down-regulated in obese pre-adipocytes
while up-regulated in obese mature adipocytes when compared to
cells from lean subjects (Table 1).
Study of the Changes in miRNAs Expression during
Adipogenesis in Obese and Lean Cell Lines
After finding this differential expression in lean and obese cell
lines, we aimed to study the miRNA expression profiles during
adipogenesis. Interestingly, most miRNAs fell along a diagonal
and negative line in the intensity scatter plot when undifferentiated
cells and differentiated adipocytes were compared, indicating that
the most of analyzed miRNAs were highly modulated during in
vitro adipogenesis (Figure 1). Despite the expression profile
indicated that major changes occurred in mature adipocytes
(MAs) at 14th day, the increased or decreased levels of the most of
these miRNAs were also detected in adipocytes at 7th day after
starting differentiation protocol (Figure 1). The most pronounced
changes for miRNAs expression pattern were detected in cells
from lean subjects, in whom miRNAs expression changed more
acutely between undifferentiated adipocytes and adipocytes at
both day 7 and 14 (r =20.202 and r =20.747, respectively,
p,0.0001; Figure 1A), compared with cells from the obese at day
7 and 14 (r = 0.353 and r =20.552, respectively, p,0.0001;
Figure 1B).
Seventy miRNAs (8.8%) were significantly (p,0.0001) up- (37
miRNAs) or down-regulated (33 miRNAs) during adipogenesis
(61.2-fold) in subcutaneous fat cells (Figure 2). The most
remarkable were miR-503 (26.7-fold), miR-221 (24.9-fold),
miR-424 (24.6-fold), miR-210 (24.3-fold) and miR-31* (22.6-
fold), that were down-regulated in mature adipocytes. On the
other side, miR-378 (6.6-fold), miR-30c (5.1-fold), miR-30a (4.0-
fold), miR-30b (3.1-fold), miR-30e (3.1-fold), miR-30a* (2.8-fold)
and miR-34a (2.5-fold), were up-regulated in mature adipocytes
(Figure 2). Notably, of these 70 miRNAs, 55 were common for
both obese and lean cell lines, including those that suffered the
major changes.
Of those 70 miRNAs up- or down-regulated during adipocyte
differentiation, 2 of the most significantly over-expressed (miR-30c
and miR-378) and 4 of the most down-regulated (miR-210, miR-
221, miR-424 and miR-503) were selected for validation by semi-
quantitative Real Time-PCR. It should be noted that, while 3 of
these miRNAs (miR-30c, miR-210 and miR-221) have been
previously described as obesity and/or adipogenesis-related
[11,26], the 3 others (miR-503, miR-378 and miR-424) were
not. The RT-PCR results confirmed our findings for the most of
the cases in both in vitro and in vivo data [Supplemental data, SI;
Figure S1].
We then analyzed the miRNA expression profile in relation
with the expression of lipogenic key-factor. The expression of 6
well-known lipo/adipogenic key-genes and/or markers of adipo-
cyte differentiation, namely Fatty Acid Synthase (FAS), Acetyl-
Coenzyme A Carboxylase alpha (ACC), Fatty Acid Binding
Protein 4 (FABP4), Peroxisome Proliferator-activated Receptor
Gamma (PPARg), Adiponectin (ADIPOQ), and Retinol Binding
Protein 4 (RBP4), was assessed by RT-PCR. As expected, the gene
expression of all these factors increased during adipocyte
differentiation [Figure S2, Plots]. Thus, FAS, ACC, FABP4, PPARg,
ADIPOQ and RBP4 gene expression levels were significantly and
directly correlated with miR-30c and miR-378 but significantly
and inversely related with miR-210, miR-221, miR-503 and miR-
424 expression levels in RNA samples from cell lines [Figure S2].
Study of miRNA Expression in Subcutaneous Fat from
Obese Subjects
To further substantiate our findings, we studied miRNAs
expression profiles in human subcutaneous adipose tissue. The
expression of 799 mature miRNAs was assessed in 28 human
subcutaneous fat biopsies from non-obese (n = 6) and obese with
(n = 9) and without (n = 13) Type-2 Diabetes Mellitus (DM-2)
women. Anthropometric and metabolic characteristics are sum-
marized in Table S1.
Most miRNAs fell along a diagonal but positive line in the
intensity scatter plot when obese (without and with DM-2) were
compared to non-obese individuals (Figure 3, r = 0.64 or r = 0.49,
respectively; both p,0.0001). However, the expression of 11
miRNAs (1.4% of the 799 miRNAs) significantly differed between
obese with or without DM-2 and non-obese subjects [Figure 4 and
Table S2]. Of note, miR-185, miR-139-5p, miR-484, and miR-
130b were down-regulated in obese without DM-2 when
compared to non-obese subjects while the expression of miR-
99a, miR-1229, miR-125b, miR-221 and miR-199a-5p was up-
regulated [Figure 4A and Table S2]. In obese subjects with DM-2,
the expression of miR-K12-7, miR-484 and miR-130b, was down-
regulated, while miR-1229, miR-199a-5p, miR-221 and miR-
125b, were up-regulated compared with non-obese subjects
[Figure 4B and Table S2]. Finally, when comparing obese
subjects with DM-2 with non-DM-2 obese subjects, the only
miRNA that significantly differed was miR-30a*, down-regulated
(21.2-fold, p = 0.03) in the former group [Table S2].
In concordance with our results, the expression of 17 mature
miRNAs (2.1%) correlated significantly (p,0.05) with parameters
of obesity (BMI) and/or lipid metabolism (fasting triglycerides)
[Table S3]. Fifteen of these miRNAs were directly or inversely
related to BMI. Importantly, among these 15 miRNAs, miR-130b
(r =20.406, p= 0.032), miR-210 (r =20.362, p = 0.049), miR-
100 (r = 0.411, p = 0.030), miR-221 (r = 0.436, p= 0.020) and
miR-125 (r = 0.477, p= 0.010) were down-regulated during
differentiation. On the other hand, miR-34a was positively
associated with BMI (r = 0.385, p = 0.043) and up-regulated in
mature adipocytes (Figure 2). Of note there, miR-10a, miR-34a,
miR-100 (in both pre-adipocytes and mature adipocytes), miR-210
and miR-99a (only in mature adipocytes) were up-regulated in cell
lines from obese subjects (Table 1) and correlated with BMI
[Table S3] while miR-221 (in both pre-adipocytes and adipocytes),
miR-210 (in pre-adipocytes) and miR-125b (in adipocytes) were
significantly down-regulated (Table 1).
Finally, the subcutaneous fat expression of 3 miRNAs was
significantly correlated with fasting triglycerides in these 28
individuals according to univariate expression analyses [Table
S3]. Among miRNAs correlated with fating triglycerides, only
miR-210 (r =20.388, p = 0.040) was down-regulated during
adipogenesis.
Discussion
In this genome wide miRNA profiling study of 723 human and
76 viral in undifferentiated, in vitro differentiated adipocytes, and
adipose tissue biopsies, the most remarkable findings were: 1) the
expression of 40 (in pre-adipocytes) and 31 (in adipocytes) mature
miRNAs significantly differed according to obesity; 2) the
MiRNAs, Adipocytes & Fat Depots
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differential expression of 70 miRNAs during normal fat cell
development; and 3) the expression pattern of 22 miRNAs in
human subcutaneous adipose tissue was associated with param-
eters of adipose tissue physiology, glucose metabolism and/or
obesity status. Thereby, it was possible not only to uncover the
possible role of some miRNAs during normal fat cell development
but also to generate a map of miRNA deregulation associated with
obesity and related disorders.
1) Differential miRNA Expression between Lean and
Obese Cell Lines before and after In Vitro Differentiation
and during Adipogenesis
MiR-10a (in both pre-adipocytes and mature adipocytes), miR-
34a, miR-100, miR-30a (only in pre-adipocytes), miR-99a and
miR-210 (only in mature adipocytes) were up-regulated in cells
and subcutaneous fat depots from obese when compared to those
obtained from lean individuals. Otherwise, the most pronounced
changes for miRNAs expression profile during differentiation were
detected in cells from lean subjects.
2) Differential Expression of 70 miRNAs during Normal
Fat Cell Development
Our genome wide miRNA screening identified, for first
time, many differentially regulated miRNAs during human
adipocyte differentiation. Of note were miR-221, miR-222,
miR-100 and miR-125b, down-regulated during adipogenesis
and associated with BMI in human adipose tissue samples.
Both miR-221 and miR-222 have been described to inhibit
endothelial cell migration, proliferation, and angiogenesis [29]
while down-regulation of miR-100 and miR-125b has been
associated with some malignancies [30]. Xie et al. also
identified miR-221 and miR-125b as down-regulated during
in vitro differentiation of mice 3T3-L1 cells [11]. However,
miR-221 was up-regulated in adipocytes from obese mice. In
the 3T3-L1 cell line, the findings with miR-100, miR-107,
miR-148a and miR-30c were similar to those described here in
human adipocytes [11].
Table 1. Significant (p,0.0001) fold-changes for miRNA
expression in in vitro cultured pre-adipocytes and mature
adipocytes between subcutaneous fat cells from obese
(BMI.30.0 Kg/m2) and lean (BMI,25.0 Kg/m2) individuals.
Groups
Pre-adipocytes
(Obese vs. Lean)
Mature
adipocytes
(Obese vs. Lean)
miRNAs Fold-changes
hsa-miR-542-5p 1.61
hsa-miR-214 1.54
hsa-miR-181a 1.52 1.24
hsa-miR-10a{ 1.50 1.38
hsa-let-7e 1.41 1.23
hsa-miR-503 1.39
hsa-let-7b 1.37 1.24
hsa-miR-768-3p 1.34 1.24
hsa-miR-542-3p 1.28
hsa-miR-30a 1.27
hsa-miR-342-3p 1.27 1.23
hsa-miR-28-5p 1.24
hsa-miR-410 1.24 1.21
hsa-miR-34a{ 1.23
hsa-miR-100{ 1.23
hsa-miR-30a{ 1.20
hsa-miR-923 21.21 1.52
hsa-miR-221* 21.21
hsa-miR-34b* 21.21 21.43
hsa-miR-143 21.21
hsa-let-7f 21.22
hsa-miR-193a-3p 21.22 21.21
hsa-miR-140-3p 21.22
hsa-miR-450a 21.23
hsa-miR-210{{ 21.24 1.48
hsa-miR-26b 21.25
hsa-miR-10b 21.25 21.25
hsa-miR-101 21.26 21.28
hsa-let-7c 21.28
hsa-miR-98 21.29 21.21
hsa-miR-23a 21.30
hsa-miR-22* 21.34 21.42
hsa-miR-337-3p 21.38 21.23
hsa-miR-31 21.39 21.34
hsa-miR-365 21.43 21.38
hsa-miR-137 21.46 21.45
hsa-miR-494 21.55
hsa-miR-29b 21.82 21.93
hsa-miR-221{ 21.88 21.84
hsa-miR-29c 22.33
hsa-let-7i 1.21
hsa-miR-125b{ 21.24
hsa-miR-195 21.22
hsa-miR-224 1.43
hsa-miR-26a 21.26
Groups
Pre-adipocytes
(Obese vs. Lean)
Mature
adipocytes
(Obese vs. Lean)
miRNAs Fold-changes
hsa-miR-29a 21.21
hsa-miR-376c 1.26
hsa-miR-424 21.35
hsa-miR-455-3p 1.48
hsa-miR-99a{ 1.21
Italic: down-regulated in fat cells from obese.
Normal: up-regulated in fat cells from obese.
Bold: outstanding when integrating results from cells and subcutaneous fat
tissue.
{Subcutaneous fat expression is direct and significantly (p,0.05) correlated with
BMI.
{{Subcutaneous fat expression is inverse and significantly (p,0.05) correlated
with BMI.
{Subcutaneous fat expression is down-regulated (21.2-fold, p = 0.03) in Obese
and DM-2 subjects.
doi:10.1371/journal.pone.0009022.t001
Table 1. Cont.
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MiR-503, the most down-regulated miRNA during differenti-
ation, has been previously found over-expressed in retinoblastoma
tumor tissue as compared to normal human retina [31] and
involved in mouse pancreas development [32]. Also related to
pancreas development and regulation, the cluster of miRNAs
related to miR-30 (miR-30a, b, c, d and e) increased during
adipocyte maturation as well as during differentiation of
pancreatic islet-derived mesenchymal cells into hormone-produc-
ing cells [32–34]. Moreover, this family of miRNAs has been
recently related to cell cycle and stress response through NF-kB
inactivation [35]. Since NF-kB has been shown as an obligatory
mediator of adipose tissue inflammatory responses associated with
decreased adipocyte differentiation [36], the observation of miR-
30s up-regulation during adipocyte differentiation is in agreement
with these findings.
On the other hand, miR-210 was up-regulated in pre-
adipocytes and inversely associated with BMI and triglycerides.
This miR-210 is linked to hypoxic stress response, a well
recognized component of the tumor environment [37]. miR-
15a, miR-101 and miR-185 were also significantly up-regulated
during adipocyte differentiation in a previous work [28].
Our findings are also in agreement with those of Esau et al.
[27], that identified a similar expression pattern regarding miR-
30c, miR-30a*, miR-30d, miR-196, miR-107, miR-30b and miR-
Figure 1. miRNA expression profiling during adipogenesis. Scatter plot showing comparison of miRNA expression profiles between
undifferentiated human pre-adipocytes (Day 0) and adipocytes during differentiation at 7th day (grey diamonds) or mature adipocytes at 14th day
(black circles) after inducing differentiation of stem-cells from subcutaneous fat depots of both lean (Fig. 1A) or obese (Fig. 1B) subjects.
doi:10.1371/journal.pone.0009022.g001
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100 during differentiation of human adipocytes. However, these
authors found that miR-143 and miR-103 were significantly up-
regulated in differentiated human fat cells. We observed that miR-
143 was, in fact, down-regulated during human adipocyte
maturation while miR-103 did not change significantly. Similar
discrepant results were observed for miR-130a and miR-130b
expression levels. The origin of fat cells (fat samples from
subcutaneous or visceral fat depots) could explain these discrep-
ancies between studies.
Working with in vitro differentiated human adipocytes, Karbi-
ener et al. [38] have recently shown the anti-adipogenic properties
of miR-27b which, able to blunt the induction of PPARc, needs to
be down-regulated during adipocyte differentiation, in concor-
dance with our in vitro results.
3) The Expression Pattern of miRNAs in Human
Subcutaneous Adipose Tissue Is Associated with
Parameters of Adipose Tissue Physiology, Glucose
Metabolism and/or Obesity Status
Several miRNAs (miR-125b, miR-130b and miR-221) were
found to be down-regulated both in mature adipocytes and in
subcutaneous fat from obese subjects with or without DM-2.
Klo¨ting et al. [26] identified several miRNAs associated with
obesity and co-morbidities. Interestingly, miR-27a, miR-140 and
miR-155, down-regulated in subcutaneous fat from DM-2
patients [26], were also down-regulated during adipocyte
differentiation. On the other hand, miR-30e expression was
increased in mature adipocytes. MiR-30a* was also identified as
up-regulated in mature adipocytes but down-regulated in obese
and DM-2 when compared with obese non-DM-2 individuals.
Klo¨ting et al. [26] also described miR-210 as down-regulated in
subcutaneous fat from DM-2 individuals when compared to
healthy individuals. According to our data, miR-210 was down-
regulated during adipocyte differentiation but not in DM-2
subjects.
Of those miRNAs significantly associated with BMI in the study
by Klo¨ting et al. [26], miR-34a was confirmed to be correlated
with adiposity parameters, up-regulated in cultured pre-adipocytes
from obese subjects and during differentiation, while miR-145 was
intensely down-regulated during cell differentiation. Finally, miR-
95, significantly associated with adipocyte size in the aforemen-
tioned study [26], increased significantly during adipocyte
differentiation (current results).
The discrepant data between studies [26] might arise from
different criteria for selecting and grouping subjects or from
different technologies. In this sense, TaqManH MicroRNA
Assays technology might be more sensitive than microarrays.
Moreover, it should be noted that, in the latter study, a
comparative Ct method was used where miR-16 served as
Figure 2. Specific miRNAs expression regulation during adipogenesis. Expressions of miRNAs significantly deregulated during
differentiation. MiRNAs expression levels are normalized to an internal control and plotted as fold changes in Log2-ratio scale for day 7 vs. day 0
(grey bars) and day 14 vs. day 0 (black bars). Log2-ratios of 2-class comparisons are symmetric around 0 (while a Log2-ratio of 1 means 2-fold up-
regulation, a Log2-ratio of 21 means 2-fold down-regulation as compared to day 0 miRNAs levels). Data are expressed as mean6 SEM (n = 6). All the
represented miRNAs (70 of the 799 analyzed miRNAs) showed ANOVA P-values,0.0001 for comparisons between groups and fold-changes over 1.2-
fold or under 21.2-fold day 0 miRNA expression levels.
doi:10.1371/journal.pone.0009022.g002
Figure 3. miRNAs expression profiling in human subcutaneous
fat. Scatter plot showing comparison of miRNA expression profiles
between subcutaneous fat from non-obese (n = 6) and obese non-DM-2
(n = 13, grey diamonds) or obese and DM-2 (n = 9, black circles) women.
doi:10.1371/journal.pone.0009022.g003
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endogenous control to normalize the expression levels of target
miRNAs. Since miR-16 seems to be, according to our data
(Fig. 2), significantly increased during adipocyte differentiation,
this aspect could influence significantly the reported findings
[26].
Integrated Results
Several miRNAs, namely miR-221, miR-125b, miR-100, miR-
130b, miR-210, miR-30a*, miR-34a, miR-503 and miR-185,
were outstanding when integrating results from cells and
subcutaneous fat tissue together. While miR-221, miR-125b,
miR-34a and miR-100 were up-regulated and miR-130b, miR-
210 and miR-185 were down-regulated in obese subjects; miR-
130b and miR-210 were both down-regulated during differenti-
ation and in subcutaneous fat depots from obese subjects.
However, some miRNAs were down-regulated during adipocyte
differentiation and maturation (miR-221, miR-125b and miR-
100) while up-regulated in obese subjects. Otherwise, miR-185
was up-regulated in mature adipocytes while down-regulated in
obese men. These findings were contrary to our expectations, as
far as miRNAs up-regulation both in obese subjects and in
differentiated adipocytes was expected to fit, since the develop-
ment of adiposity mostly depends on maturation of undifferenti-
ated adipocytes and adipocyte hypertrophy in adults [39,40]. This
capacity of fat depots is preserved at any age from a pool of
dormant precursors cells [41]. Only miR-34a was found to be
positively up-regulated during adipogenesis and associated posi-
tively with BMI.
Current findings seem to hint at a negative relationship, with
most miRNAs positively linked to adiposity and down-regulated
during adipocyte differentiation. This fact could be in relation with
the hyperplasic component of obesity, with increased fat cells
precursors (i.e. pre-adipocytes) [7]. Interestingly, McLaughlin
et al. [42] and Pasarica et al. [43] reported increased small
adipocytes in subcutaneous fat from obese and type-2 diabetic
subjects in two independent studies, suggesting the presence of an
impairment in adipose cell differentiation and early maturation of
pre-adipocytes linked to obesity-associated co-morbidities (such as
insulin-resistance and type-2 diabetes). Of note, miR-30a*, down-
regulated in obese and DM-2 when compared with obese with-
out DM-2 subjects, was significantly up-regulated in mature
adipocytes.
In summary, the remarkable inverse miRNA profile revealed
for human pre-adipocytes and mature adipocytes hints at a closely
crosstalk between miRNAs and adipogenesis. As far as revealed by
this study, miRNAs may represent biomarkers for obesity and
obesity-related complications. However, further investigations will
be required to evaluate the functional consequences of these
Figure 4. Human subcutaneous miRNAs expressions. Expressions of miRNAs are normalized to an internal control and plotted as fold-changes
in a Log2-scale for obese non-DM-2 vs. non-obese (Fig. A) or obese and DM-2 vs. non-obese (Fig. B). Data are expressed as mean 6 SEM. The
represented miRNAs showed in each case ANOVA P-values,0.05 for comparisons between groups and fold-changes over 1.2-fold or under21.2-fold
subcutaneous fat from non-obese miRNA level.
doi:10.1371/journal.pone.0009022.g004
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findings and the biochemical function of most of the analyzed
miRNAs, which remains elusive.
Supporting Information
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0009022.s001 (0.07 MB
DOC)
Figure S1 Validation of microarray results. For 6 of the most
regulated miRNAs in both in vitro (pre-adipocytes (.), adipocytes
(¤) at 7th day and mature adipocytes (m) at 14th day) and in vivo
(subcutaneous fat biopsies from non-obese (#), obese non-DM-2
(¤) and obese and DM-2 (%) subjects) analyses, microarray results
were validated by RT-PCR assays. RT-PCR expression values for
all miRNAs are the ratio relative to previously tested and validated
miRNA endogenous control (RNU48). Microarray values are the
ratio relative to an internal control.
Found at: doi:10.1371/journal.pone.0009022.s002 (4.79 MB TIF)
Figure S2 Relationship between miRNAs and lipogenic path-
way gene expression. Plots: Comparisons by RT-PCR of key-
lipogenic mRNAs levels during adipogenesis. Expressions of all
mRNAs are normalized to internal control (Cyclophilin A, PPIA)
and plotted as fold-changes relative to this endogenous control at
day 0, 7 and 14. Data are expressed as mean 6 SEM (n= 6) for
FAS, ACC, FABP4, ADIPOQ, PPARg and RBP4. Table:
Significant correlates of miRNA and the selected adipo/lipogen-
ic-related gene expression levels. The abbreviations used are: FAS,
Fatty Acid Synthase; ACC, Acetyl-CoA Carboxilase; FABP4,
Fatty Acid-Binding protein 4; PPARg, Peroxisome proliferator-
activated receptor gamma; ADIPOQ, Adiponectin; RBP4,
Retinol binding protein 4.
Found at: doi:10.1371/journal.pone.0009022.s003 (0.25 MB EPS)
Table S1 Anthropometrical and clinical characteristics of study
subjects.
Found at: doi:10.1371/journal.pone.0009022.s004 (0.05 MB
DOC)
Table S2 Significant fold-changes for miRNA expression in
subcutaneous adipose tissue.
Found at: doi:10.1371/journal.pone.0009022.s005 (0.01 MB
PDF)
Table S3 Significant correlates of miRNA expression in
subcutaneous fat samples.
Found at: doi:10.1371/journal.pone.0009022.s006 (0.01 MB
PDF)
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